Lung Cancer — 5-Minute Journal Club with Dr Natalie Vokes: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
About this episode
Dr. Natalie Vokes discusses the role of circulating tumor DNA assays in lung cancer management.
Dr Natalie Vokes from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of lung cancer. CME information and select publications here .
People in this episode
Host: Dr. Neil Love
Guest: Dr Natalie Vokes
Topics covered
- lung cancer
- circulating tumor DNA
- assays
- cancer management
- medical research
Keywords
- lung cancer
- circulating tumor DNA
- assays
- cancer management
- CME
Mentioned in this episode
Organizations: The University of Texas MD Anderson Cancer Center, Lung Cancer Update
More episodes of Lung Cancer Update
- EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
- Extensive-Stage Small Cell Lung Cancer — Current Patterns of Care with First-Line and Maintenance Therapy
- Extensive-Stage Small Cell Lung Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy
- Lung Cancer — Proceedings from a Symposium Held in Partnership with the American Oncology Network
- HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach
- Lung Cancer — 5-Minute Journal Club Issue 4 with Dr Aaron Lisberg: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
Explore listener stats, chart rankings, contacts and more on the Lung Cancer Update podcast page.